MedPage Today on MSN
Cannabinoids for mental, substance use disorders 'rarely justified,' study suggests
Cannabis compounds may reduce symptoms for some disorders, but evidence quality is low ...
In this video interview, Marc Buyse, ScD, founder and CEO of IDDI, examines the most common threats to trial data reliability ...
Regular physical activity provides evidence of being an effective way to relieve symptoms of anxiety and depression in people ...
Adding almonds to the diet of adults with obesity enhances inflammatory cytokine profiles and diet quality, highlighting a ...
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder affecting children and adults.
Generations have grown up opening baseball card packs and blind boxes and bags, and then trading and selling the items they ...
In this video interview, Marc Buyse, ScD, founder and CEO of IDDI, reflects on the gap between sponsor expectations and statistical reality, drawing on lessons from the COVID era to argue for more ...
In patients with diabetes and multivessel CAD, ticagrelor fails to meet noninferiority criteria compared with prasugrel at ...
When MRI offered no clear answer in suspected prostate cancer, the use of prostate-specific membrane antigen (PSMA)-PET/CT ...
A web-based tool that incorporates patient preference in antidepressant selection was associated with a significant decrease ...
Psychosocial interventions offered limited benefits for reducing symptoms and substance use in patients with schizophrenia ...
April Health reports that the Collaborative Care Model effectively addresses the mental health gap in rural America by integrating behavioral health into primary care.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果